Biosimilars for psoriasis: clinical studies to determine similarity
Biosimilars are drugs that are similar, but not identical, to originator biologics. Pre-clinical analytical studies are required to show similarity on a molecular and structural level, but efficacy and safety studies in humans are essential to ultimately determine biosimilarity. In this review writt...
Sparad:
| Huvudupphovsmän: | , , , , , , , , , , , , |
|---|---|
| Materialtyp: | Revisão |
| Språk: | engelska |
| Publicerad: |
2016
|
| Länkar: | https://doi.org/10.1111/bjd.15067 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|